期刊文献+

恶性疟原虫膜蛋白Pfs25在毕赤酵母中的组成型表达 被引量:6

Constitutive Expression of Plasmodium falciparum Transmission-Blocking Vaccine Antigen Pfs25 in Pichia pastoris
下载PDF
导出
摘要 目的:Pfs25蛋白是传播阻断型恶性疟疾疫苗的侯选抗原,在毕赤酵母中表达Pfs25蛋白,并对表达产物进行鉴定。方法:参照GenBank中公布的pfs25基因序列,通过毕赤酵母喜好密码子分析人工合成目的基因;采取定向克隆策略构建重组表达质粒pfs25/pGAPZαA,经BstXⅠ线性化,电转染法转化酵母菌株GS115,在Zeocin抗性的筛选培养基上获得表达目的基因的pfs25/pGAPZαA/GS115重组酵母菌,SDS-PAGE和Western印迹检测表达产物;通过在YPD培养基上传代培养和目的基因表达,验证重组菌株的遗传稳定性。结果:在毕赤酵母中表达了Pfs25蛋白,且重组菌株遗传性质稳定。结论:为研制基于Pfs25蛋白的传播阻断型恶性疟疾疫苗奠定了基础。 Objective: Malaria is the mosquito-borne infectious disease and Pfs25 protein is the antigen for transmission-blocking vaccine.The aim of this study is to express the Pfs25 protein in Pichia pastoris.Methods: According to the codon-like principle for P.pastoris,the target gene was synthesized and inserted into a yeast constitutive vector pGAPZαA to construct recombinant plasmid pfs25/pGAPZαA,and then transformed the host P.pastoris GS115 genome by electroporation.The expressed product was identified by SDS-PAGE and Western blot.The recombinant P.pastoris was analyzed for genetic stability.Results: The Pfs25 protein was expressed successfully in P.pastoris,and the yeast transformants still had the foreign gene after eight passages in YPD medium.Conclusion: This study laid a foundation of future research in malaria transmission-blocking vaccine.
出处 《生物技术通讯》 CAS 2011年第6期785-788,共4页 Letters in Biotechnology
关键词 传播阻断型恶性疟疾疫苗 Pfs25蛋白 毕赤酵母 组成型表达 malaria transmission-blocking vaccine Pfs25 protein Pichia pastoris constitutive expression
  • 相关文献

参考文献14

  • 1WHO. World Malaria Report 2009[EB/OL]. http://www.who.int/malaria/world_alaria_report_2009 /en/index.html.
  • 2Kaslow D C, Quakyi I A, Syin C, et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains[J]. Nature, 1988,333(6168):74-76.
  • 3Barr P J, Green K M, Gibson H L, et al. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission- blocking immunity in experimental animals [J]. J Exp Med, 1991,174(5):1203-1208.
  • 4Zou L, Miles A P, Wang J, et al. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials[J]. Vaccine, 2003,21(15):1650- 1657.
  • 5Wu Y, Ellis R D, Shaffer D, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51[J]. PloS one, 2008,3(7):e2636.
  • 6Singh M B, Bhalla P L. Recombinant expression systems for allergen vaccines[J]. Inflamm Allergy Drug Targets, 2006,5(1): 53-59.
  • 7Waterham H R, Digan M E, Koutz P J, et al. Isolation of the Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase gene and regulation and use of its promoter[J]. Gene, 1997,186(1): 37-44.
  • 8Vassileva A, Chugh D A, Swaminathan S, et al. Expression of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris using the GAP promoter[J]. J Biotechnol, 2001,88(1): 21-35.
  • 9Boer H, Teeri T T, Koivula A. Characterization of Trichoderma reesei cellobiohydrolase Cel7A secreted from Pichia pastoris us- ing two different promoters[J]. Biotechnol Bioeng, 2000,69(5): 486-494.
  • 10Cos O, Ramon R, Montesinos J L, et al. Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review[J]. Microbial Cell Factories, 2006,5:17.

二级参考文献1

  • 1赵翔,复旦学报,1999年,38卷,5期,510页

共引文献191

同被引文献70

  • 1蔡瑜,向本春,席德慧,刘升学,都业娟.苹果褪绿叶斑病毒库尔勒分离物外壳蛋白基因的克隆、原核表达及特异抗血清的制备[J].农业生物技术学报,2005,13(4):533-537. 被引量:11
  • 2谢涛,王红宁.外源基因在巴斯德毕赤酵母中多拷贝整合的研究进展[J].生物技术通讯,2006,17(3):415-417. 被引量:10
  • 3孙鹏,秦贵信.蒸汽处理对纯化大豆抗原含量及免疫原性的影响[J].中国兽医学报,2006,26(5):551-554. 被引量:22
  • 4WHO. World Malaria Report 2009[ EB/OL]. http://www, who. inl/ malaria/world malaria report 2009/en/index. html.
  • 5Kaslow DC, Quakyi IA, Syin C, et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-likc domains [ J ]. Nature, 1988, 333(6168): 74-76.
  • 6Zou L, Miles AP, Wang J, et al. Expression of malaria transmissionblocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials[J]. Vaccine, 2003, 21 (15) : 1650 - 1657.
  • 7Stowers AW, Keister DB, Muratova O, et al. A region of plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies [ J ]. Infection and Immunity, 2000, 10 (68) : 5530 -5538.
  • 8Takeshi A , Ai K, Hitoshi O. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field [ J ]. Infect Immun, 2005, 11 : 7375 - 7380.
  • 9Wu Y, Ellis RD, Shaffer D, et al. Phase 1 trim of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51 [J]. Plos One, 2008, 3(7) : e2636.
  • 10Ban" PJ, Green KM, Gibson HL, et al. Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immu- nity in experimental animals [J]. J Exper Medicine, 1991, 11 (174) : 1203 -1208.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部